1-(2-氯苄甲酰基)哌嗪盐酸盐 | 13754-45-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(2-氯苄甲酰基)哌嗪盐酸盐
• 英文名称: 1-(2-chlorobenzoyl)-piperazine
• 英文别名: (2-Chlorophenyl)(piperazin-1-yl)methanone；(2-chlorophenyl)-piperazin-1-ylmethanone
• CAS: 13754-45-5
• 化学式: C₁₁H₁₃ClN₂O
• mdl: MFCD04116574
• 分子量: 224.69
• InChiKey: UKXGHBPPSTVPJO-UHFFFAOYSA-N

物化性质

• 熔点：
  195 °C
• 沸点：
  383.8±37.0 °C(Predicted)
• 密度：
  1.231±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  香豆素-3-甲酰氯 、 1-(2-氯苄甲酰基)哌嗪盐酸盐 在 potassium carbonate 作用下， 以 乙醇 、 丙酮 为溶剂， 反应 6.0h， 以16%的产率得到3-(4-(2-Chlorobenzoyl)piperazine-1-carbonyl)coumarin
  参考文献：
  名称：

  Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues

  摘要：

  Three series (series A-C) of coumarin analogues with phenylpiperazine functions as substitution were designed and synthesized for studying their potential for treating Alzheimer's (AD) disease. Their anticholinesterase activities were assayed according to Ellmann's method against freshly prepared acetylcholinesterase (AChE) from Electrophorus electricus using donepezil as the reference compound. Pharmacological study and preliminary structure-activity relationships showed that coumarins with substitution on positions 3 and/or 4 have parallel anti-AchE activities compared with the reference compound. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.07.068
• 作为产物：
  描述：

  Tert-butyl 4-(2-chlorobenzoyl)piperazine-1-carboxylate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 1-(2-氯苄甲酰基)哌嗪盐酸盐
  参考文献：
  名称：

  展望可药物治疗的人碳酸酐酶同工型的活性位点腔的边缘。

  摘要：

  我们报告了一系列的取代的4-（4-芳酰基哌嗪-1-羰基）苯磺酰胺（5a-s）的合成和生化评估，这些药物被开发为可药用的碳酸酐酶（CA）亚型的抑制剂，作为鉴定新疗法的工具。X射线晶体学证实，这类苯磺酰胺通过苯磺酰胺部分对金属离子的典型锚定和活性中心腔中部/顶部区域的尾部介导识别而与CA结合。化合物5e（R = 2-Cl）对脑表达的hCA VII具有相关的选择性。对于抑制剂5o（R = 3-NO2），发现对肿瘤表达的hCA IX / hCA XII的结合亲和力和选择性优于无处不在的hCA I / hCA II的最佳平衡。

  DOI：

  10.1021/acsmedchemlett.0c00062

文献信息

• Synthesis, Characterization, and Anti-Inflammatory Activities of Methyl Salicylate Derivatives Bearing Piperazine Moiety
  作者：Jingfen Li、Yong Yin、Lisheng Wang、Pengyun Liang、Menghua Li、Xu Liu、Lichuan Wu、Hua Yang

  DOI：10.3390/molecules21111544

  日期：——

  In this study, a new series of 16 methyl salicylate derivatives bearing a piperazine moiety were synthesized and characterized. The in vivo anti-inflammatory activities of target compounds were investigated against xylol-induced ear edema and carrageenan-induced paw edema in mice. The results showed that all synthesized compounds exhibited potent anti-inflammatory activities. Especially, the anti-inflammatory

  在这项研究中，合成和表征了一系列新的16个带有哌嗪部分的水杨酸甲酯衍生物。研究了目标化合物的体内抗炎活性，以对抗小鼠的二甲苯酚诱导的耳水肿和角叉菜胶诱导的爪水肿。结果表明，所有合成的化合物均显示出有效的抗炎活性。特别地，在相同剂量下，化合物M15和M16的抗炎活性高于阿司匹林，甚至等于消炎痛。此外，在RAW264.7巨噬细胞中进行了四种目标化合物的体外细胞毒性活性和抗炎活性，发现化合物M16以剂量依赖性方式显着抑制脂多糖（LPS）诱导的白介素（IL）-6和肿瘤坏死因子（TNF）-α的释放。此外，发现化合物M16可减弱LPS诱导的环氧合酶（COX）-2的上调。当前的初步研究可能会为开发新型安全的抗炎药提供信息。
• Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
  作者：Hongyu Qin、Jian Zhang、Yilu Zhao、Lihui Zhang、Jinhong Feng、Lei Zhang

  DOI：10.3389/fphar.2022.1054616

  日期：——

  Introduction: Development of Poly (ADP-ribose) polymerase (PARP) inhibitors has been extensively studied in cancer treatment. Olaparib, the first approved PARP inhibitor, showed potency in the inhibition of both BRCA (breast cancer associated)-mutated and BRCA-unmutated cancers.Methods: Aiming to the discovery of olaparib analogs for the treatment of cancer, structural modifications were performed based on the

  简介：聚（ADP-核糖）聚合酶 (PARP) 抑制剂的开发已在癌症治疗中得到广泛研究。奥拉帕尼是第一个获批的 PARP 抑制剂，显示出抑制 BRCA（乳腺癌相关）突变和 BRCA 未突变癌症的效力。方法：为了发现用于治疗癌症的奥拉帕尼类似物，进行了基于奥拉帕尼的脚手架。在第一系列中，羰基还原为CH2个导致 PARP1 抑制活性降低。在保留原始羰基的情况下，通过引入酰肼和芳香族氮芥基团，衍生出具有强效 PARP1 抑制活性的分子。合成的化合物在 PARP1 酶抑制筛选、基于癌细胞的抗增殖测定、细胞周期停滞和细胞凋亡研究中进行了评估。的抗癌效力体外抗增殖试验。与奥拉帕尼和苯丁酸氮芥相比，分子 C2 在抑制多种 BRCA 未突变细胞系方面也表现出显着的效力。进一步分析揭示了 C2 在诱导 G2/M 期细胞周期停滞和促进细胞凋亡方面的作用。讨论：总的来说，奥拉帕尼-苯丁酸氮芥杂化分子 (C2) 可用作进一步药物设计的先导化合物。
• Urbain; Schumer; Gubin, European Journal of Medicinal Chemistry, 1982, vol. 17, # 4, p. 359 - 364
  作者：Urbain、Schumer、Gubin、Descamps

  DOI：——

  日期：——
• Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents
  作者：Xian-Chao Cheng、Xin-Yong Liu、Wen-Fang Xu、Xiu-Li Guo、Ning Zhang、Yu-Ning Song

  DOI：10.1016/j.bmc.2009.03.012

  日期：2009.4

  A series of novel acylpiperazinyl Ligustrazine derivatives was designed, synthesized, and their protective effects on damaged ECV-304 cells and antiplatelet aggregation activities were evaluated. The results showed that compound E33 displayed most potential protective effects on the ECV-304 cells damaged by hydrogen peroxide, and compound E1 was found to be the most active antiplatelet aggregation agent. Structure-activity relationships were briefly discussed. (C) 2009 Elsevier Ltd. All rights reserved.
• Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics
  作者：Alka Bali、Komal Sharma、Abhishek Bhalla、Suman Bala、Dinesh Reddy、Anant Singh、Anil Kumar

  DOI：10.1016/j.ejmech.2010.02.008

  日期：2010.6

  A series of 1-(aryloxypropyl)-4-(chloroaryl) piperazines have been synthesized and the target compounds evaluated for atypical antipsychotic activity in apomorphine induced mesh climbing and stereotypy assays in mice. The compounds 11 and 12 have emerged as important lead compounds showing potential atypical antipsychotic profile. The physicochemical similarity of the new analogs with respect to standard drugs clozapine, ketanserin, ziprasidone and risperidone was assessed by calculating from a set of 10 physicochemical properties using software programs. The test compounds demonstrated good similarity values with respect to the standard drugs. The potential of these compounds to penetrate the blood brain barrier (log BB) was computed through an online software program and the values obtained for the compounds suggest a good brain permeation.